Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based Integra LifeSciences Holdings has launched Integra flowable wound matrix, an advanced wound care device that is based on the company's proven collagen technology and provides an alternative to filling deep soft tissue or tunneling wounds in diabetic foot and venous leg ulcers.
Subscribe to our email newsletter
Integra has received 510(k) clearance from the FDA to market flowable wound matrix in the US.
Tom Tarca, vice president of marketing for the extremity reconstruction business, Integra, said: “We are excited to utilize our extensive collagen technology to design, engineer and manufacture a new wound matrix, which specifically fills a clinical need in the treatment of wounds.”